• A case of mother and child with CANDLE syndrome: Diagnosis and subsequent treatment with baricitinib
• A cohort analysis of familial partial lipodystrophy from two Mediterranean countries
• A Novel Subtype of Acquired Generalized Lipodystrophy Associated With Subcutaneous Panniculitis-Like T-cell Lymphoma
• A rapid action plan to improve diagnosis and management of lipodystrophy syndromes
• A Rare Case of Congenital Generalized Lipodystrophy
• A rare LMNA missense mutation causing a severe phenotype of mandibuloacral dysplasia type A: a case report
• Acute pharmacodynamic responses to sitagliptin: Drug-induced increase in early insulin secretion in oral glucose tolerance test
• ADH1B, the adipocyte-enriched alcohol dehydrogenase, plays an essential, cell-autonomous role in human adipogenesis
• Adipose tissue in health and disease
• Adipose transplantation improves metabolism and atherosclerosis but not perivascular adipose tissue abnormality or vascular dysfunction in lipodystrophic <em>Seipin/Apoe</em> null mice
• Adipose transplantation improves metabolism and atherosclerosis but not PVAT abnormality or vascular dysfunction in lipodystrophic <em>Seipin/Apoe</em> null mice
• An unusual case of acquired generalized lipodystrophy (panniculitis variety)
• Analysis of the Thigh Aesthetic Profiles: One of Physical Ideal Body Proportions
• Associations of adipose insulin resistance index with leg (gluteofemoral) fat (inverse) and serum alanine aminotransferase (positive) in young Japanese women
• Behavioral variant of frontotemporal dementia in carriers of biallelic TREM2 variants: cases study
• Biological Depiction of Lipodystrophy and Its Associated Challenges Among HIV AIDS Patients: Literature Review
• Case report: A novel splice-site mutation of <em>MTX2</em> gene caused mandibuloacral dysplasia progeroid syndrome: the first report from China and literature review
• Case report: First Chinese patient with family partial lipodystrophy type 6 due to novel compound heterozygous mutations in the LIPE gene
• Case report: two novel PPARG pathogenic variants associated with type 3 familial partial lipodystrophy in Brazil
• Characteristics of nuclear architectural abnormalities of myotubes differentiated from Lmna^H222P/H222P skeletal muscle cells
• Circulating exosomal circRNA-miRNA-mRNA network in a familial partial lipodystrophy type 3 family with a novel PPARG frameshift mutation c.418dup
• Clinical and Ultrasound Efficacy of Topical Hypertonic Cream (Jovita Osmocell^®) in the Treatment of Cellulite: A Prospective, Monocentric, Double-Blind, Placebo-Controlled Study
• Comprehensive analysis of morbidity and mortality patterns in familial partial lipodystrophy patients: insights from a population study
• Congenital Generalized Lipodystrophy in a Division 1 Female Sprinter
• Correction: Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta‑analysis
• Corrigendum to "Adipocytokine dysregulation, abnormal glucose metabolism, and lipodystrophy in HIV-infected adolescents receiving protease inhibitors" [Cytokine 136 (2020) 155145]
• Cullin 3 RING E3 ligase inactivation causes NRF2-dependent NADH reductive stress, hepatic lipodystrophy, and systemic insulin resistance
• Cxcr4 regulates a pool of adipocyte progenitors and contributes to adiposity in a sex-dependent manner
• Deletion of adipocyte Sine Oculis Homeobox Homolog 1 prevents lipolysis and attenuates skin fibrosis
• Determinants of Metabolic Syndrome Among Patients Receiving Anti-Retro-Viral Treatment in A Tertiary Hospital, Central Ethiopia: Unmatched Case-Control Study
• Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journey
• Diagnostic and referral pathways in patients with rare lipodystrophy and insulin-resistance syndromes: key milestones assessed from a national reference center
• Disease flares with baricitinib dose reductions and development of flare criteria in patients with CANDLE/PRAAS
• Disentangling the detrimental effects of local from systemic adipose tissue dysfunction on articular cartilage in the knee
• Drug-Induced Atypical Lipodystrophy
• Dysfunctional adipocytes promote tumor progression through YAP/TAZ-dependent cancer-associated adipocyte transformation
• Early B-cell transcription factor-2 defect as a novel cause of lipodystrophy: disruption of the adipose tissue character and integrity
• Echocardiographic Alterations of Cardiac Geometry and Function in Patients with Familial Partial Lipodystrophy
• Effects of glucocorticoids on adipose tissue plasticity
• Effects of Metreleptin in Patients with Generalized Lipodystrophy Before vs After the Onset of Severe Metabolic Disease
• Efficacy of multivitamin support following bariatric surgery in patients with obesity: a prospective observational study
• Forecasting and validating fat mass ratio models through anthropometric measurements and health-related factors among people with HIV: a cross-sectional investigation
• Generalized lipodystrophies: Clinical characterization and physiopathology
• Gestational and neonatal outcomes of women with partial Dunnigan lipodystrophy
• GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy
• Heterogeneity and high prevalence of bone manifestations, and bone mineral density in congenital generalized lipodystrophy subtypes 1 and 2
• Hippo-YAP/TAZ signalling coordinates adipose plasticity and energy balance by uncoupling leptin expression from fat mass
• HIV and adipose tissue: A long history linked to therapeutic classes of antiretrovirals
• Homozygous TREM2 c.549del; p.(Leu184Serfs*5) variant causing Nasu-Hakola disease in three siblings in a consanguineous Iraqi family: Case report and review of literature
• Hypertriglyceridemia Results From an Impaired Catabolism of Triglyceride-Rich Lipoproteins in PLIN1-Related Lipodystrophy
• Identification of ibuprofen targeting CXCR family members to alleviate metabolic disturbance in lipodystrophy based on bioinformatics and in vivo experimental verification
• Immune Checkpoint Inhibitors-Associated Generalized Lipodystrophy: Reconstructive Challenges of an Emerging and Distinct Form of Lipodystrophy
• Impaired signaling pathways on Berardinelli-Seip congenital lipodystrophy macrophages during Leishmania infantum infection
• Increased Genetic Risk for β-Cell Failure Is Associated With β-Cell Function Decline in People With Prediabetes
• Influence of diet and body weight in treatment-resistant acquired partial lipodystrophy after hematopoietic stem cell transplantation and its potential for metabolic improvement
• Insulin-Induced Lipohypertrophy
• Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report
• Leptin replacement therapy in the management of lipodystrophy syndromes
• Lipodystrophia centrifugalis abdominals infantilis presenting as a giant ulceration and treatment with hydroxychloroquine and baricitinib
• Lipodystrophy following Covid-19 Vaccination: A case report
• Lipodystrophy in HIV/AIDS: a comparison between physically active, and inactive HIV-infected vs. uninfected men
• Lipodystrophy Prevalence, "Lipodystrophy-Like Phenotypes," and Diagnostic Challenges
• Lipomatoses
• Long-term glucocorticoid infusion impairs epididymal adipocyte metabolism and maturation and affects miR-150-5p actions
• Loss of HD-PTP function results in lipodystrophy, defective cellular signaling, and altered lipid homeostasis
• Loss-of-function variants affecting the STAGA complex component SUPT7L cause a developmental disorder with generalized lipodystrophy
• M2 macrophage-derived TGF-β induces age-associated loss of adipogenesis through progenitor cell senescence
• Mesenchymal-specific Alms1 knockout in mice recapitulates metabolic features of Alström syndrome
• Metreleptin (Myalepta): CADTH Reimbursement Recommendation: Indication: As an adjunct to diet as a replacement therapy to treat the complications of leptin deficiency in lipodystrophy (LD) patients: with confirmed congenital generalised LD (Berardinelli-S
• Monogenic diabetes in children: An underdiagnosed and poorly managed clinical dilemma
• Monogenic interferon-mediated diseases: novel phenotype and genotype characteristics from a Saudi population
• Myocardin reverses insulin resistance and ameliorates cardiomyopathy by increasing IRS-1 expression in a murine model of lipodystrophy caused by adipose deficiency of vacuolar H(+)-ATPase V0d1 subunit
• Navigating Lipodystrophy: Insights from Laminopathies and Beyond
• Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial
• OTULIN deficiency: focus on innate immune system impairment
• PAQR4 regulates adipocyte function and systemic metabolic health by mediating ceramide levels
• Partial lipodystrophy: Clinical presentation and treatment
• Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases
• PPA1 promotes adipogenesis by regulating the stability of C/EBPs
• Preclinical evaluation of tissue-selective gene therapies for congenital generalised lipodystrophy
• Prevalence and Correlates of Self-Reported ADHD Symptoms in Bariatric Patients: Focus on Mood and Anxiety Comorbidity, Disordered Eating, and Temperamental Traits
• Prevalence of clinical characteristics of lipodystrophy in the US adult population in a healthcare claims database
• Primary disease of adipose tissue: When to think about and how to evaluate it in clinical practice?
• Regulated regeneration of adipose tissue in lipodystrophic <em>Agpat2</em>-null mice partially ameliorates hepatic steatosis
• Regulation of hepatic lipogenesis by asymmetric arginine methylation
• Rituximab Therapy for Insulin Allergy in Type-1 Diabetes Mellitus
• Role of APOC3 3238C/G, APOB 12669G/A and SCARB1 1050C/T polymorphisms, their expression in patients of HIV-associated lipodystrophy
• Role of Na/K-ATPase α1 caveolin-binding motif in adipogenesis
• Seipin Deficiency Leads to Energy Dyshomeostasis via Inducing Hypothalamic Neuroinflammation and Aberrant Expression of Neuropeptides
• Semaglutide in people with HIV-associated lipohypertrophy
• SIRT1 Serum Concentrations in Lipodystrophic Syndromes
• Spigelian hernia
• The emerging role of fat-inducing transcript 2 in endoplasmic reticulum proteostasis and lipoprotein biogenesis
• The Endo-lift Laser (Intralesional 1470 nm Diode Laser) for Dermatological Aesthetic Conditions: A Systematic Review
• The Significance of Precise Diabetes Diagnosis: A Case of Euglycemic Diabetic Ketoacidosis Induced by the Introduction of Empagliflozin with Simultaneous Reduction of Insulin Dosage
• Tissue fibrosis associated depletion of lipid-filled cells
• Understanding Cardiac Alterations in Familial Partial Lipodystrophy: Insights from Echocardiography
• Unsupervised clustering identified clinically relevant metabolic syndrome endotypes in UK and Taiwan Biobanks
• When and how to evaluate adipose tissue in clinical practice? DEXA, impedancemetry
• Wiedemann-Rautenstrauch syndrome. The first description of a clinical case in the Russian Federation